Rush Medical Center Home Page Information for healthcare Professionals Rush University
FIND A DOCTOR
PATIENT & VISTOR SERVICES
HEALTH INFORMATION
CLINICAL SERVICES
EVENTS & CLASSES
RUSH NEWS ROOM
CLINICAL TRIALS
RESEARCH AT RUSH
NURSING AT RUSH
WORK AT RUSH
GIVING TO RUSH

Bookmark This Page
Clinical Trails at Rush The Effect of Passive Immunization on Mild Alzheimers Disease
Clinical Trial Protocol ID
13042402

Clinical Trial Investigator Name
Neelum Aggarwal

Clinical Trial Title

Effect of Passive Immunization on the Progression of Mild Alzheimer’s Disease



Clinical Trial Protocol Description

The purpose of this 18-month study is to test whether solanezumab will slow the cognitive and functional decline of Alzheimer’s disease in patients with mild Alzheimer’s disease. At Rush University Medical Center, we anticipate recruiting approximately 10 people. Treatment or matching placebo will be assigned randomly.



Clinical Trial Eligibility Criteria

In order to participate you must have:

  • Are 55 to 90 years of age
  • Have been diagnosed with Alzheimer’s disease
  • Have a study partner willing to accompany you to all study visits 
You will be excluded from the study if  you:
  • Are unwilling or unable to undergo MRI, PET and lumbar puncture procedures, or do not have good venous access
  • Have medical conditions that are not stable or that require adjustments of your medications
This is a partial list of inclusion and exclusion criteria. 




Contact Name Jeanine Pilat
Contact Phone 312-942-1733
Promotional Information

Clinical Trials Home
Alzheimer's Disease Trials
The Effect of Passive Immunization on Mild Alzheimers Disease

   
Find a Doctor | Patient & Visitor Services | Health Information
Clinical Services | Events & Classes | Rush News Room | Clinical Trials
Research At Rush
Disclaimer | Privacy Statement | Site Map

© Rush University Medical Center, Chicago, Illinois